AbbVie and Gedeon Richter Plc. ('Richter') today announced a new discovery, co-development and license agreement to advance novel targets for the potential treatment of neuropsychiatric conditions.

A Step Toward Better Sleep and Improved Wellbeing Sleep is an essential component of a healthy life, yet millions of ...

Medicare Advantage (MA) insurers, namely industry titans UnitedHealth Group and Humana, could be using health risk ...

But the good news is, getting tested is usually quick, easy, and painless. And STDs can be cured or treated. Planned Parenthood health centers offer STD testing and treatment, and our caring and ...

The Company is currently developing CYB003, a proprietary deuterated psilocin program, about to enter Phase 3 studies for the adjunctive treatment of major depressive disorder and CYB004 ... as “may”, ...

The NHS Mental Health Dashboard brings together key data from across mental health services to measure the performance of the NHS in delivering our ambitions set out in the NHS Long Term Plan » Mental ...